Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risks for glucose intolerance.

L J Klaff, J P Palmer

    Cardiology Clinics
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Cardiovascular disease is a leading cause of death for people with diabetes. This review explores risk factors contributing to cardiovascular disease in diabetic patients, examining glucose intolerance as a potential independent risk factor.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.

    Genes and immunity·2015
    Same author

    Islet autoimmunity in phenotypic type 2 diabetes patients.

    Diabetes, obesity & metabolism·2013
    Same author

    Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients.

    Clinical and experimental immunology·2013
    Same author

    Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation.

    Clinical and experimental immunology·2011
    Same author

    Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.

    The Journal of clinical endocrinology and metabolism·2010
    Same author

    The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.

    Genes and immunity·2010
    Same journal

    At the Edge of the Possible: A New Standard for Cardiovascular Critical Care.

    Cardiology clinics·2026
    Same journal

    End-of-Life Care in the Cardiovascular Intensive Care Unit.

    Cardiology clinics·2026
    Same journal

    Strategies to Reduce Failure to Rescue after Cardiac Surgery.

    Cardiology clinics·2026
    Same journal

    Embracing Enhanced Recovery After Cardiac Surgery Program.

    Cardiology clinics·2026
    Same journal

    Post-Heart Transplantation Intensive Care Unit Recovery: A Phase-Based Approach.

    Cardiology clinics·2026
    Same journal

    A Practical Guide to Intensive Care Unit Management after Left Ventricular Assist Device Implantation.

    Cardiology clinics·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Cardiology
    • Metabolic Diseases

    Background:

    • Cardiovascular disease (CVD) is a primary cause of death and disability among individuals with diabetes mellitus.
    • Diabetic patients face a significantly elevated risk of developing various cardiovascular complications.
    • Understanding the interplay of risk factors is crucial for effective CVD prevention in diabetes.

    Purpose of the Study:

    • To describe the prevalence of cardiovascular disease in diabetic populations.
    • To explore factors influencing the development of cardiovascular disease in diabetes.
    • To investigate the role of glucose intolerance as an independent risk factor for CVD.

    Main Methods:

    • Literature review and synthesis of existing research on cardiovascular disease in diabetes.

    Related Experiment Videos

  • Analysis of epidemiological data and clinical studies.
  • Exploration of the interaction between glucose intolerance and other established CVD risk factors.

    • Main Results:

    • Cardiovascular disease is highly prevalent in diabetic individuals, contributing significantly to morbidity and mortality.
    • Multiple factors, including hyperglycemia, hypertension, dyslipidemia, and obesity, contribute to CVD development in diabetes.
    • The independent contribution of glucose intolerance to cardiovascular risk is a subject of ongoing research and debate.

    Conclusions:

    • Cardiovascular disease poses a major threat to individuals with diabetes.
    • Comprehensive management of diabetes and its associated risk factors is essential for reducing CVD.
    • Further research is needed to fully elucidate the independent role of glucose intolerance in cardiovascular risk stratification.